Inventor

TSYPIN MAXIM

US20 patents

⚠️ This page may combine multiple inventors who share the name “TSYPIN MAXIM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TSYPIN MAXIM

BIODESIX INC

Method and system for determining whether a drug will be effective on a patient with a disease

Monitoring treatment of cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples

Method and system for determining whether a drug will be effective on a patient with a disease

Selection of head and neck cancer patients for treatment with drugs targeting EGFR pathway

Selection of non-small-cell lung cancer patients for treatment with monoclonal antibody drugs targeting EGFR pathway

Selection of colorectal cancer patients for treatment with drugs targeting EGFR pathway

Deep-MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof

Method for reliable classification of samples in clinical diagnostics using an improved method of classification

Predictive test for melanoma patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods

Deep MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof

Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods

Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods

ROEDER HEINRICH

Method and system for determining whether a drug will be effective on a patient with a disease

Monitoring treatment of colorectal cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples

Monitoring treatment of head and neck cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples

Monitoring treatment of head and neck cancer patients with drugs EGFR pathway using mass spectrometry of patient samples

Monitoring treatment of colorectal cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples

RÖDER HEINRICH

Method and system for determining whether a drug will be effective on a patient with a disease

Method and system for determining whether a drug will be effective on a patient with a disease

ROEDER JOANNA

Method and system for validation of mass spectrometer machine performance